Embark Veterinary Inc., a Boston, MA-based provider of an advanced canine DNA test, raised $4.5m in funding.
The round was led by Founder Collective, Freestyle and ThirdKind, with participation from Bill Maris’ new fund Section 32, Anne Wojcicki, and SV Angel.
The company, which has raised $6.5m in total funding, intends to use the capital to expand their canine genetic testing suite for pet parents, breeders, and veterinarians.
Co-founded by Adam and Ryan Boyko, Embark currently offers – in partnership with the Cornell University College of Veterinary Medicine – a Dog DNA Test that tracks over 200,000 genetic markers, offering ancestry analysis as well as an extensive overview of both genetic disease risk and heritable traits, allowing users to understand their dog’s health, plan for their pet’s future and provide their dog with the best personalized care possible.
Since its launch in May 2016, Embark has built a database of tens of thousands of dogs and has delivered thousands of dog owners information about their pet’s breed, traits, and genetic health dispositions.